Home  >  Products  >  PRKACA (protein kinase, cAMP-dependent, catalytic, alpha) Blocking Peptide (the N terminal of PRKACA)(100ug)
PRKACA (protein kinase, cAMP-dependent, catalytic, alpha) Blocking Peptide (the N terminal of PRKACA)(100ug)

PRKACA (protein kinase, cAMP-dependent, catalytic, alpha) Blocking Peptide (the N terminal of PRKACA)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-PRKACA Antibody(ARP57828_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP57828
Size: 100ug
Weight: 40kDa
Gene: 5566
Format: Lyophilized powder
Target: cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. The protein encoded by this gene is a member of the Ser/Thr protein kinase family and is a catalytic subunit of cAMP-dependent protein kinase. Alternatively spliced transcript variants encoding distinct isoforms have been observed.
Alternative names: MGC102831; MGC48865; PKACA
See Full Product Listings >